STOCK TITAN

Zomedica Stock Price, News & Analysis

ZOM NYSE

Company Description

Overview

Zomedica Corp (NYSE American: ZOM) is an innovative veterinary healthcare company dedicated to enhancing animal health through advanced diagnostic and therapeutic solutions. Specializing in point-of-care technologies for companion animals and equines, the company offers a robust portfolio designed to address the unmet needs of clinical veterinarians and improve practice efficiencies. With a focus on novel diagnostic platforms and non-invasive therapeutic devices, Zomedica empowers veterinary professionals to lower operating costs, increase productivity, and ultimately deliver superior patient care.

Product Portfolio and Technological Innovations

Zomedica's offerings include an array of cutting-edge products that integrate advanced imaging, automated diagnostic capabilities, and innovative therapeutic modalities. The company is renowned for its TRUFORMA diagnostic platform, a system that utilizes proprietary sensor technologies for accurate and rapid testing. Alongside this, its digital cytology system and remote monitoring solutions enhance the precision of diagnoses and clinical decision-making. Additionally, Zomedica’s novel therapeutic devices are designed to accelerate healing processes and minimize patient discomfort through non-invasive methods.

Market Position and Competitive Edge

Operating within the broader veterinary health industry, Zomedica has established a strong market position by addressing both clinical and business challenges faced by veterinarians. The company differentiates itself with a deep commitment to research and development, leveraging the insights of practicing veterinary professionals to tailor its product suite. This focus on innovation has allowed Zomedica to not only meet the growing demand for efficient, point-of-care diagnostic tools but also to set new operational standards across veterinary practices. Its comprehensive solutions enable veterinarians to conduct tests quickly and accurately, thereby reducing turnaround times and enhancing patient care.

Operational Excellence and Global Reach

Headquartered in Michigan, Zomedica operates from world-class manufacturing and distribution facilities that underscore its commitment to quality and efficiency. With manufacturing operations in key U.S. regions, the company ensures consistent delivery of high-quality products to its domestic and international markets. Zomedica's strategic partnerships in various regions further complement its mission of expanding access to advanced veterinary care globally. The company’s investments in cleanroom technologies and automated production lines not only enhance manufacturing capacity but also streamline logistics and distribution processes.

Benefits to Veterinary Practices

The integrated solutions offered by Zomedica are specifically designed to improve the workflow and profitability of veterinary practices. By automating complex diagnostic procedures and providing rapid, lab-quality results at the point of care, the company enables veterinarians to focus on delivering improved patient outcomes. Enhanced diagnostic speed, reduced operational costs, and increased efficiency are key factors driving the widespread adoption of Zomedica’s technologies in veterinary clinics across varied market segments.

Commitment to Innovation and Quality Care

Underpinned by the insights of industry experts and built on robust scientific research, Zomedica remains committed to continuous improvement in veterinary care. The company’s strategic focus on innovation, combined with its rigorous quality control measures, supports a wide spectrum of diagnostic and therapeutic applications. This dedication not only bolsters the confidence of veterinary professionals in adopting its technologies but also reinforces the company’s reputation for excellence, expertise, and trustworthiness in the veterinary healthcare industry.

Conclusion

Zomedica Corp stands out as a pioneering force in the veterinary health sector by delivering comprehensive, technology-driven solutions that enhance both clinical outcomes and practice management. Through its innovative product portfolio and strategic operational excellence, Zomedica continues to influence the evolution of veterinary diagnostics and therapeutics, enabling veterinarians to provide top-tier care to companion and equine patients.

Stock Performance

$—
0.00%
0.00
Last updated:
-35.34 %
Performance 1 year
$95.3M
Market Cap
979.9M
Shares outstanding

SEC Filings

No SEC filings available for Zomedica.

Financial Highlights

$27,285,000
Revenue (TTM)
-$46,982,000
Net Income (TTM)
-$0.05
Diluted EPS (TTM)
-$23,630,000
Operating Cash Flow
-172.19%
Net Profit Margin
-187.11%
Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Zomedica (ZOM)?

The current stock price of Zomedica (ZOM) is $0.0973 as of March 5, 2025.

What is the market cap of Zomedica (ZOM)?

The market cap of Zomedica (ZOM) is approximately 95.3M.

What is the revenue (TTM) of Zomedica (ZOM) stock?

The trailing twelve months (TTM) revenue of Zomedica (ZOM) is $27,285,000.

What is the net income of Zomedica (ZOM)?

The trailing twelve months (TTM) net income of Zomedica (ZOM) is -$46,982,000.

What is the earnings per share (EPS) of Zomedica (ZOM)?

The diluted earnings per share (EPS) of Zomedica (ZOM) is -$0.05 on a trailing twelve months (TTM) basis.

What is the operating cash flow of Zomedica (ZOM)?

The operating cash flow of Zomedica (ZOM) is -$23,630,000.

What is the profit margin of Zomedica (ZOM)?

The net profit margin of Zomedica (ZOM) is -172.19%.

What is the operating margin of Zomedica (ZOM)?

The operating profit margin of Zomedica (ZOM) is -187.11%.

What is the gross margin of Zomedica (ZOM)?

The gross profit margin of Zomedica (ZOM) is 69.95%.

What is the current ratio of Zomedica (ZOM)?

The current ratio of Zomedica (ZOM) is 8.76, indicating the company's ability to pay short-term obligations.

What is the gross profit of Zomedica (ZOM)?

The gross profit of Zomedica (ZOM) is $19,087,000 on a trailing twelve months (TTM) basis.

What is the operating income of Zomedica (ZOM)?

The operating income of Zomedica (ZOM) is -$51,053,000.

What is the core business of Zomedica Corp?

Zomedica Corp focuses on providing innovative diagnostic and therapeutic solutions for veterinary applications, enhancing care for companion and equine animals.

Which markets does Zomedica serve?

The company serves the veterinary healthcare market with products used in both companion animal and equine practices across domestic and international regions.

What type of products does Zomedica offer?

Zomedica offers a range of point-of-care diagnostic platforms, imaging systems, and therapeutic devices designed to streamline practice workflows and improve patient outcomes.

How does Zomedica differentiate itself in the veterinary industry?

By integrating advanced technology with clinically-driven insights, Zomedica delivers precise, rapid diagnostic results and innovative therapeutic solutions that address critical unmet needs in veterinary practices.

What role does the TRUFORMA diagnostic platform play in their offerings?

The TRUFORMA platform provides automated, high-precision diagnostic capabilities at the point of care, reducing turnaround times and enhancing the accuracy of veterinary diagnostics.

How does Zomedica improve operational efficiencies for veterinary clinics?

Their innovative products automate complex diagnostic processes and streamline clinical workflows, leading to faster decision-making, lower costs, and improved patient care.

Why is Zomedica considered an expert in veterinary healthcare?

The company’s commitment to R&D, its science-backed product innovations, and strategic partnerships with veterinary professionals collectively reinforce its reputation for expertise and trustworthiness in the industry.